Healthcare ranking
Top 25 digestive disease clinical trial sponsors 2026
Eli Lilly and GSK share first place with 18 trials each. The list ranks companies worldwide by the number of new interventional trials they lead in this area.
Top 10 at a glance
The full list
| Rank | Company | Headquarters | new industry-sponsored clinical trials (trials) |
|---|---|---|---|
| 1 | Eli Lilly | United States | 18 |
| 1 | GSK | United Kingdom | 18 |
| 3 | AusperBio | China | 15 |
| 4 | Takeda | Japan | 14 |
| 5 | Sanofi | France | 13 |
| 6 | AstraZeneca | United Kingdom | 12 |
| 7 | Boehringer Ingelheim | Germany | 11 |
| 7 | Johnson & Johnson (Janssen) | United States | 11 |
| 9 | AbbVie | United States | 10 |
| 9 | Vertex Pharmaceuticals | United States | 10 |
| 11 | Chia Tai Tianqing (Sino Biopharm) | China | 9 |
| 11 | Merck & Co. (MSD) | United States | 9 |
| 13 | Regeneron | United States | 7 |
| 13 | Valenta Pharm | Russia | 7 |
| 15 | Mirum Pharmaceuticals | United States | 6 |
| 16 | Zydus Lifesciences | India | 5 |
| 16 | Addpharma | South Korea | 5 |
| 18 | Gilead Sciences | United States | 4 |
| 18 | Jiangsu Hengrui Pharmaceuticals | China | 4 |
| 18 | Novo Nordisk | Denmark | 4 |
| 18 | Roche | Switzerland | 4 |
| 18 | bioLytical Laboratories | Canada | 4 |
| 18 | Fujian Akeylink Biotechnology | China | 4 |
| 18 | Phathom Pharmaceuticals | United States | 4 |
| 18 | Wecare Probiotics | China | 4 |
How this list is built
We counted interventional clinical trials with a company as lead sponsor and a start date from 1 November 2023 to 31 October 2026 that list a condition that falls under digestive system diseases in the standard medical subject headings; withdrawn trials are not counted. Cancer trials are counted in the cancer lists instead. Subsidiaries and name variants are merged into the parent company ("Eli Lilly and Company" and "Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)" are counted as Eli Lilly), and hospitals, universities and other non-company sponsors are left out. Companies with the same count share a rank, and all companies tied at the last place are shown.
Every position is set by the data alone, by the same rules for every company. Spotted something to update? Write to info@stratummarketresearch.com with the list and the line, and we correct it within two working days.
For ranked companies: a free badge
Ranked companies can show this badge on their website, in a press release or on LinkedIn at no cost. Pick your company, then copy the code.
Frequently asked questions
Who is number one in the digestive disease clinical trial sponsors ranking?
Eli Lilly ranks first with 18 trials (November 2023 to October 2026).
How is this ranking calculated?
We counted interventional clinical trials with a company as lead sponsor and a start date from 1 November 2023 to 31 October 2026 that list a condition that falls under digestive system diseases in the standard medical subject headings; withdrawn trials are not counted. Cancer trials are counted in the cancer lists instead. Subsidiaries and name variants are merged into the parent company ("Eli Lilly and Company" and "Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)" are counted as Eli Lilly), and hospitals, universities and other non-company sponsors are left out. Companies with the same count share a rank, and all companies tied at the last place are shown.
Can a company pay to rank higher?
Positions come only from the counts described above, and inclusion is free. Every company is ranked by the same rules.
How often is the ranking updated?
Every list is recomputed each quarter from the latest public records, and the update date is printed on the page.
Can a ranked company use the badge?
Yes. Every ranked company can use the free web badge on this page on its website, in press releases and on social media.
Custom research
Looking for a specific market?
Tell us the market, the region and the decision you are making. We reply within one working day with a scope and a date.